6. Immunotherapy and Research Methods

Immune Checkpoint Therapy — Quiz

Test your understanding of immune checkpoint therapy with 5 practice questions.

Practice Questions

Question 1

Which mechanism explains primary resistance to anti-PD-1 therapy in tumor cells with JAK1 loss-of-function mutations?

Question 2

Which gut commensal bacterium, other than Faecalibacterium, has been associated with improved clinical responses to PD-1 blockade?

Question 3

Ipilimumab can deplete intratumoral regulatory T cells via which effector mechanism?

Question 4

Elevated baseline serum lactate dehydrogenase (LDH) in patients before initiating checkpoint inhibitor therapy is associated with:

Question 5

Combining anti-PD-1 therapy with VEGF blockade enhances antitumor immunity primarily by: